Cargando…

STAT3 determines IL-4 signalling outcomes in naïve T cells

IL-4 production is associated with low-avidity, poorly cytotoxic T cell induction that contributes to viral immune evasion and the failure of T cell-based vaccines. Yet, the precise mechanisms that regulate IL-4 signalling in T cells remain elusive. Mounting evidence indicates that cells can dynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Deimel, Lachlan P., Li, Zheyi, Roy, Sreeja, Ranasinghe, Charani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131749/
https://www.ncbi.nlm.nih.gov/pubmed/34006897
http://dx.doi.org/10.1038/s41598-021-89860-7
_version_ 1783694768722673664
author Deimel, Lachlan P.
Li, Zheyi
Roy, Sreeja
Ranasinghe, Charani
author_facet Deimel, Lachlan P.
Li, Zheyi
Roy, Sreeja
Ranasinghe, Charani
author_sort Deimel, Lachlan P.
collection PubMed
description IL-4 production is associated with low-avidity, poorly cytotoxic T cell induction that contributes to viral immune evasion and the failure of T cell-based vaccines. Yet, the precise mechanisms that regulate IL-4 signalling in T cells remain elusive. Mounting evidence indicates that cells can dynamically alter their IL-4/IL-13 receptor signature to modulate downstream immune outcomes upon pathogen encounter. Here, we describe how naïve (CD62L(+)CD44(lo–mid)) CD4 and CD8 T cells distinctly engage both STAT6 and STAT3 in response to IL-4. We further show that IL-4R⍺ expression is both time- and IL-4 concentration-dependent. Remarkably, our findings reveal that STAT3 inhibition can ablate IL-4R⍺ and affect transcriptional expression of other Stat and Jak family members. By extension, the loss of STAT3 lead to aberrant STAT6 phosphorylation, revealing an inter-regulatory relationship between the two transcription factors. Moreover, IL-4 stimulation down-regulated TGF-β1 and IFN-γR1 expression on naïve T cells, possibly signifying the broad regulatory implications of IL-4 in conditioning lineage commitment decisions during early infection. Surprisingly, naïve T cells were unresponsive to IL-13 stimulation, unlike dendritic cells. Collectively, these findings could be exploited to inform more efficacious vaccines, as well as design treatments against IL-4/IL-13-associated disease conditions.
format Online
Article
Text
id pubmed-8131749
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81317492021-05-25 STAT3 determines IL-4 signalling outcomes in naïve T cells Deimel, Lachlan P. Li, Zheyi Roy, Sreeja Ranasinghe, Charani Sci Rep Article IL-4 production is associated with low-avidity, poorly cytotoxic T cell induction that contributes to viral immune evasion and the failure of T cell-based vaccines. Yet, the precise mechanisms that regulate IL-4 signalling in T cells remain elusive. Mounting evidence indicates that cells can dynamically alter their IL-4/IL-13 receptor signature to modulate downstream immune outcomes upon pathogen encounter. Here, we describe how naïve (CD62L(+)CD44(lo–mid)) CD4 and CD8 T cells distinctly engage both STAT6 and STAT3 in response to IL-4. We further show that IL-4R⍺ expression is both time- and IL-4 concentration-dependent. Remarkably, our findings reveal that STAT3 inhibition can ablate IL-4R⍺ and affect transcriptional expression of other Stat and Jak family members. By extension, the loss of STAT3 lead to aberrant STAT6 phosphorylation, revealing an inter-regulatory relationship between the two transcription factors. Moreover, IL-4 stimulation down-regulated TGF-β1 and IFN-γR1 expression on naïve T cells, possibly signifying the broad regulatory implications of IL-4 in conditioning lineage commitment decisions during early infection. Surprisingly, naïve T cells were unresponsive to IL-13 stimulation, unlike dendritic cells. Collectively, these findings could be exploited to inform more efficacious vaccines, as well as design treatments against IL-4/IL-13-associated disease conditions. Nature Publishing Group UK 2021-05-18 /pmc/articles/PMC8131749/ /pubmed/34006897 http://dx.doi.org/10.1038/s41598-021-89860-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Deimel, Lachlan P.
Li, Zheyi
Roy, Sreeja
Ranasinghe, Charani
STAT3 determines IL-4 signalling outcomes in naïve T cells
title STAT3 determines IL-4 signalling outcomes in naïve T cells
title_full STAT3 determines IL-4 signalling outcomes in naïve T cells
title_fullStr STAT3 determines IL-4 signalling outcomes in naïve T cells
title_full_unstemmed STAT3 determines IL-4 signalling outcomes in naïve T cells
title_short STAT3 determines IL-4 signalling outcomes in naïve T cells
title_sort stat3 determines il-4 signalling outcomes in naïve t cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131749/
https://www.ncbi.nlm.nih.gov/pubmed/34006897
http://dx.doi.org/10.1038/s41598-021-89860-7
work_keys_str_mv AT deimellachlanp stat3determinesil4signallingoutcomesinnaivetcells
AT lizheyi stat3determinesil4signallingoutcomesinnaivetcells
AT roysreeja stat3determinesil4signallingoutcomesinnaivetcells
AT ranasinghecharani stat3determinesil4signallingoutcomesinnaivetcells